Search - tctmd.com

Displaying 701 - 720 of 745

Sort: Relevancy | Date

News Daily News

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Jason Kahn

July 20, 2012

Presentation

Contemporary Evidence About Hospital Strategies for Reducing 30-Day Readmissions

Presenter: Elizabeth H. Bradley

July 20, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

RACE: Regional STEMI Care System Improves Time to Reperfusion, Survival

Yael L. Maxwell

June 06, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Iron Chelation Therapy Fails to Prevent Reperfusion Injury After STEMI

May 02, 2012

News Daily News

DEB-AMI Published: Drug-Eluting Balloon Fails to Impress in STEMI

April 12, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

March 23, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

L.A. McKeown

March 07, 2012

News Daily News

El Tratamiento con Células Madre Mejora Moderadamente la Función Cardiaca tras un IM Agudo

L.A. McKeown

March 07, 2012

News Daily News

Upfront Measures Shorten Transfer Time to Primary PCI

March 06, 2012

News Daily News

Study Shines Spotlight on US Readmissions After STEMI

Yael L. Maxwell

January 04, 2012

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

Advertisement

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Contemporary Evidence About Hospital Strategies for Reducing 30-Day Readmissions

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

RACE: Regional STEMI Care System Improves Time to Reperfusion, Survival

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Iron Chelation Therapy Fails to Prevent Reperfusion Injury After STEMI

DEB-AMI Published: Drug-Eluting Balloon Fails to Impress in STEMI

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Stem Cell Therapy Moderately Improves Cardiac Function After Acute MI

El Tratamiento con Células Madre Mejora Moderadamente la Función Cardiaca tras un IM Agudo

Upfront Measures Shorten Transfer Time to Primary PCI

Study Shines Spotlight on US Readmissions After STEMI

Hospital Readmission Post-PCI Linked to Increased Mortality

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content